Rheos Capital Works’s Accenture ACN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-20,000
Closed -$5.37M 74
2025
Q4
$5.37M Buy
+20,000
New +$5.08M 0.34% 61
2024
Q3
Sell
-10,000
Closed -$3.03M 106
2024
Q2
$3.03M Sell
10,000
-15,000
-60% -$4.59M 0.16% 98
2024
Q1
$8.66M Buy
+25,000
New +$9.11M 0.41% 79
2023
Q4
Sell
-98,500
Closed -$30.3M 91
2023
Q3
$30.3M Sell
98,500
-45,900
-32% -$14.5M 1.82% 17
2023
Q2
$44.6M Hold
144,400
2.4% 9
2023
Q1
$41.3M Buy
144,400
+84,000
+139% +$22.9M 2.3% 10
2022
Q4
$16.1M Hold
60,400
0.97% 32
2022
Q3
$15.5M Sell
60,400
-35,000
-37% -$10.1M 1.05% 29
2022
Q2
$26.5M Sell
95,400
-95,000
-50% -$28.5M 1.99% 4
2022
Q1
$64.2M Hold
190,400
3.09% 3
2021
Q4
$78.9M Sell
190,400
-80,300
-30% -$29.3M 3.45% 3
2021
Q3
$86.6M Hold
270,700
4.46% 2
2021
Q2
$79.8M Hold
270,700
4.03% 2
2021
Q1
$74.8M Hold
270,700
4.95% 2
2020
Q4
$70.7M Buy
270,700
+7,000
+3% +$1.68M 5.14% 2
2020
Q3
$59.6M Sell
263,700
-199,700
-43% -$45.7M 4.87% 7
2020
Q2
$99.5M Buy
463,400
+17,900
+4% +$3.39M 6.95% 3
2020
Q1
$72.7M Buy
445,500
+410,200
+1,162% +$79M 7.71% 2
2019
Q4
$7.43M Buy
+35,300
New +$6.88M 0.77% 16

Other funds holding ACN

Rheos Capital Works's ACN Position: Q1 2026 in Review

Rheos Capital Works sold out of Accenture (ACN) in Q1 2026, closing a stake of 20,000 shares — an estimated $5.37M sold.

Rheos Capital Works first reported a position in ACN in Q4 2019 and held it in 19 quarters. The position peaked at $99.5M in Q2 2020. 2,149 funds tracked by Wall St. Rank hold ACN as of Q1 2026.

  • Rheos Capital Works reported no remaining Accenture position as of Q1 2026 after selling out during the quarter.
  • Rheos Capital Works sold 20,000 Accenture shares in Q1 2026, an estimated $5.37M.
  • Rheos Capital Works first reported a position in Accenture in Q4 2019 and held it in 19 quarters.
  • Rheos Capital Works's Accenture position peaked at $99.5M in Q2 2020.
  • 2,149 funds tracked by Wall St. Rank held Accenture as of Q1 2026.

Based on Rheos Capital Works's 13F filing for Q1 2026, filed 8 May 2026.